DESIGN THERAPEUTICS INC's ticker is DSGN and the CUSIP is 25056L103. A total of 51 filers reported holding DESIGN THERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,086,523 | -62.5% | 460,391 | 0.0% | 0.03% | -58.0% |
| Q2 2023 | $2,900,463 | +9.2% | 460,391 | 0.0% | 0.07% | +9.5% |
| Q1 2023 | $2,656,456 | -43.8% | 460,391 | 0.0% | 0.06% | -44.7% |
| Q4 2022 | $4,723,612 | -38.6% | 460,391 | 0.0% | 0.11% | -42.7% |
| Q3 2022 | $7,698,000 | +19.4% | 460,391 | 0.0% | 0.20% | +5.9% |
| Q2 2022 | $6,445,000 | +15.5% | 460,391 | +33.2% | 0.19% | +34.3% |
| Q1 2022 | $5,581,000 | -22.2% | 345,597 | +3.1% | 0.14% | -15.7% |
| Q4 2021 | $7,178,000 | +46.3% | 335,247 | +0.4% | 0.17% | +61.2% |
| Q3 2021 | $4,907,000 | -25.7% | 334,050 | +0.6% | 0.10% | -21.4% |
| Q2 2021 | $6,604,000 | -32.5% | 332,050 | +1.5% | 0.13% | -38.5% |
| Q1 2021 | $9,785,000 | – | 327,250 | – | 0.21% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SR ONE CAPITAL MANAGEMENT, LP | 5,626,476 | $78,771,000 | 38.55% |
| Logos Global Management LP | 2,797,501 | $39,165,000 | 7.18% |
| Cormorant Asset Management, LP | 5,500,000 | $77,000,000 | 5.82% |
| Ghost Tree Capital, LLC | 275,000 | $3,850,000 | 2.00% |
| EcoR1 Capital, LLC | 2,634,178 | $36,878,000 | 1.27% |
| RA Capital Management | 2,186,636 | $30,613,000 | 0.82% |
| Vivo Capital, LLC | 476,589 | $6,672,000 | 0.67% |
| Avoro Capital Advisors LLC | 2,222,222 | $31,111,000 | 0.62% |
| Artal Group S.A. | 400,000 | $5,600,000 | 0.30% |
| Rock Springs Capital Management LP | 460,391 | $6,445,000 | 0.19% |